United States Scaffold-free Cell Culture Product Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Scaffold-free Cell Culture Product Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Scaffold-free Cell Culture Product Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Scaffold-free Cell Culture Product Overall Market Size
2.1 United States Scaffold-free Cell Culture Product Market Size: 2021 VS 2027
2.2 United States Scaffold-free Cell Culture Product Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Scaffold-free Cell Culture Product Sales: 2016-2027
3 Company Landscape
3.1 Top Scaffold-free Cell Culture Product Players in United States Market
3.2 Top United States Scaffold-free Cell Culture Product Companies Ranked by Revenue
3.3 United States Scaffold-free Cell Culture Product Revenue by Companies
3.4 United States Scaffold-free Cell Culture Product Sales by Companies
3.5 United States Scaffold-free Cell Culture Product Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Scaffold-free Cell Culture Product Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Scaffold-free Cell Culture Product Product Type
3.8 Tier 1, Tier 2 and Tier 3 Scaffold-free Cell Culture Product Players in United States Market
3.8.1 List of Tier 1 Scaffold-free Cell Culture Product Companies in United States
3.8.2 List of Tier 2 and Tier 3 Scaffold-free Cell Culture Product Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Scaffold-free Cell Culture Product Market Size Markets, 2021 & 2027
4.1.2 Low-adhesion Microplates
4.1.3 Hanging Drop Plates
4.1.4 3D Bioreactors
4.1.5 3D Petri Dishes
4.2 By Type - United States Scaffold-free Cell Culture Product Revenue & Forecasts
4.2.1 By Type - United States Scaffold-free Cell Culture Product Revenue, 2016-2021
4.2.2 By Type - United States Scaffold-free Cell Culture Product Revenue, 2022-2027
4.2.3 By Type - United States Scaffold-free Cell Culture Product Revenue Market Share, 2016-2027
4.3 By Type - United States Scaffold-free Cell Culture Product Sales & Forecasts
4.3.1 By Type - United States Scaffold-free Cell Culture Product Sales, 2016-2021
4.3.2 By Type - United States Scaffold-free Cell Culture Product Sales, 2022-2027
4.3.3 By Type - United States Scaffold-free Cell Culture Product Sales Market Share, 2016-2027
4.4 By Type - United States Scaffold-free Cell Culture Product Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Scaffold-free Cell Culture Product Market Size, 2021 & 2027
5.1.2 Cancer and Stem Cell Research
5.1.3 Drug Discovery and Toxicology
5.1.4 Tissue Engineering & Regenerative Medicine
5.2 By Application - United States Scaffold-free Cell Culture Product Revenue & Forecasts
5.2.1 By Application - United States Scaffold-free Cell Culture Product Revenue, 2016-2021
5.2.2 By Application - United States Scaffold-free Cell Culture Product Revenue, 2022-2027
5.2.3 By Application - United States Scaffold-free Cell Culture Product Revenue Market Share, 2016-2027
5.3 By Application - United States Scaffold-free Cell Culture Product Sales & Forecasts
5.3.1 By Application - United States Scaffold-free Cell Culture Product Sales, 2016-2021
5.3.2 By Application - United States Scaffold-free Cell Culture Product Sales, 2022-2027
5.3.3 By Application - United States Scaffold-free Cell Culture Product Sales Market Share, 2016-2027
5.4 By Application - United States Scaffold-free Cell Culture Product Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Thermo Fisher (US)
6.1.1 Thermo Fisher (US) Corporation Information
6.1.2 Thermo Fisher (US) Overview
6.1.3 Thermo Fisher (US) Scaffold-free Cell Culture Product Sales and Revenue in United States Market (2016-2021)
6.1.4 Thermo Fisher (US) Scaffold-free Cell Culture Product Product Description
6.1.5 Thermo Fisher (US) Recent Developments
6.2 Corning (US)
6.2.1 Corning (US) Corporation Information
6.2.2 Corning (US) Overview
6.2.3 Corning (US) Scaffold-free Cell Culture Product Sales and Revenue in United States Market (2016-2021)
6.2.4 Corning (US) Scaffold-free Cell Culture Product Product Description
6.2.5 Corning (US) Recent Developments
6.3 Lonza (Switzerland)
6.3.1 Lonza (Switzerland) Corporation Information
6.3.2 Lonza (Switzerland) Overview
6.3.3 Lonza (Switzerland) Scaffold-free Cell Culture Product Sales and Revenue in United States Market (2016-2021)
6.3.4 Lonza (Switzerland) Scaffold-free Cell Culture Product Product Description
6.3.5 Lonza (Switzerland) Recent Developments
6.4 Merck (Germany)
6.4.1 Merck (Germany) Corporation Information
6.4.2 Merck (Germany) Overview
6.4.3 Merck (Germany) Scaffold-free Cell Culture Product Sales and Revenue in United States Market (2016-2021)
6.4.4 Merck (Germany) Scaffold-free Cell Culture Product Product Description
6.4.5 Merck (Germany) Recent Developments
6.5 ReproCELL (Japan)
6.5.1 ReproCELL (Japan) Corporation Information
6.5.2 ReproCELL (Japan) Overview
6.5.3 ReproCELL (Japan) Scaffold-free Cell Culture Product Sales and Revenue in United States Market (2016-2021)
6.5.4 ReproCELL (Japan) Scaffold-free Cell Culture Product Product Description
6.5.5 ReproCELL (Japan) Recent Developments
6.6 InSphero (Switzerland)
6.6.1 InSphero (Switzerland) Corporation Information
6.6.2 InSphero (Switzerland) Overview
6.6.3 InSphero (Switzerland) Scaffold-free Cell Culture Product Sales and Revenue in United States Market (2016-2021)
6.6.4 InSphero (Switzerland) Scaffold-free Cell Culture Product Product Description
6.6.5 InSphero (Switzerland) Recent Developments
6.7 Global Cell Solutions (US)
6.7.1 Global Cell Solutions (US) Corporation Information
6.7.2 Global Cell Solutions (US) Overview
6.7.3 Global Cell Solutions (US) Scaffold-free Cell Culture Product Sales and Revenue in United States Market (2016-2021)
6.7.4 Global Cell Solutions (US) Scaffold-free Cell Culture Product Product Description
6.7.5 Global Cell Solutions (US) Recent Developments
6.8 Synthecon (US)
6.8.1 Synthecon (US) Corporation Information
6.8.2 Synthecon (US) Overview
6.8.3 Synthecon (US) Scaffold-free Cell Culture Product Sales and Revenue in United States Market (2016-2021)
6.8.4 Synthecon (US) Scaffold-free Cell Culture Product Product Description
6.8.5 Synthecon (US) Recent Developments
6.9 3D Biotek (US)
6.9.1 3D Biotek (US) Corporation Information
6.9.2 3D Biotek (US) Overview
6.9.3 3D Biotek (US) Scaffold-free Cell Culture Product Sales and Revenue in United States Market (2016-2021)
6.9.4 3D Biotek (US) Scaffold-free Cell Culture Product Product Description
6.9.5 3D Biotek (US) Recent Developments
6.10 Kuraray (Japan)
6.10.1 Kuraray (Japan) Corporation Information
6.10.2 Kuraray (Japan) Overview
6.10.3 Kuraray (Japan) Scaffold-free Cell Culture Product Sales and Revenue in United States Market (2016-2021)
6.10.4 Kuraray (Japan) Scaffold-free Cell Culture Product Product Description
6.10.5 Kuraray (Japan) Recent Developments
6.11 Hamilton Company (US)
6.11.1 Hamilton Company (US) Corporation Information
6.11.2 Hamilton Company (US) Overview
6.11.3 Hamilton Company (US) Scaffold-free Cell Culture Product Sales and Revenue in United States Market (2016-2021)
6.11.4 Hamilton Company (US) Scaffold-free Cell Culture Product Product Description
6.11.5 Hamilton Company (US) Recent Developments
6.12 Mimetas (Netherlands)
6.12.1 Mimetas (Netherlands) Corporation Information
6.12.2 Mimetas (Netherlands) Overview
6.12.3 Mimetas (Netherlands) Scaffold-free Cell Culture Product Sales and Revenue in United States Market (2016-2021)
6.12.4 Mimetas (Netherlands) Scaffold-free Cell Culture Product Product Description
6.12.5 Mimetas (Netherlands) Recent Developments
6.13 Emulate (US)
6.13.1 Emulate (US) Corporation Information
6.13.2 Emulate (US) Overview
6.13.3 Emulate (US) Scaffold-free Cell Culture Product Sales and Revenue in United States Market (2016-2021)
6.13.4 Emulate (US) Scaffold-free Cell Culture Product Product Description
6.13.5 Emulate (US) Recent Developments
6.14 Nano3D Biosciences (US)
6.14.1 Nano3D Biosciences (US) Corporation Information
6.14.2 Nano3D Biosciences (US) Overview
6.14.3 Nano3D Biosciences (US) Scaffold-free Cell Culture Product Sales and Revenue in United States Market (2016-2021)
6.14.4 Nano3D Biosciences (US) Scaffold-free Cell Culture Product Product Description
6.14.5 Nano3D Biosciences (US) Recent Developments
6.15 QGel (Switzerland)
6.15.1 QGel (Switzerland) Corporation Information
6.15.2 QGel (Switzerland) Overview
6.15.3 QGel (Switzerland) Scaffold-free Cell Culture Product Sales and Revenue in United States Market (2016-2021)
6.15.4 QGel (Switzerland) Scaffold-free Cell Culture Product Product Description
6.15.5 QGel (Switzerland) Recent Developments
7 United States Scaffold-free Cell Culture Product Production Capacity, Analysis
7.1 United States Scaffold-free Cell Culture Product Production Capacity, 2016-2027
7.2 Scaffold-free Cell Culture Product Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Scaffold-free Cell Culture Product Supply Chain Analysis
9.1 Scaffold-free Cell Culture Product Industry Value Chain
9.2 Scaffold-free Cell Culture Product Upstream Market
9.3 Scaffold-free Cell Culture Product Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Scaffold-free Cell Culture Product Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of TablesTable 1. Key Players of Scaffold-free Cell Culture Product in United States Market
Table 2. Top Scaffold-free Cell Culture Product Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Scaffold-free Cell Culture Product Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Scaffold-free Cell Culture Product Revenue Share by Companies, 2016-2021
Table 5. United States Scaffold-free Cell Culture Product Sales by Companies, (K Units), 2016-2021
Table 6. United States Scaffold-free Cell Culture Product Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Scaffold-free Cell Culture Product Price (2016-2021) & (USD/Unit)
Table 8. Manufacturers Scaffold-free Cell Culture Product Product Type
Table 9. List of Tier 1 Scaffold-free Cell Culture Product Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Scaffold-free Cell Culture Product Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Low-adhesion Microplates
Table 12. Major Manufacturers of Hanging Drop Plates
Table 13. By Type - United States Scaffold-free Cell Culture Product Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Scaffold-free Cell Culture Product Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Scaffold-free Cell Culture Product Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Scaffold-free Cell Culture Product Sales (K Units), 2016-2021
Table 17. By Type - United States Scaffold-free Cell Culture Product Sales (K Units), 2022-2027
Table 18. By Application - United States Scaffold-free Cell Culture Product Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Scaffold-free Cell Culture Product Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Scaffold-free Cell Culture Product Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Scaffold-free Cell Culture Product Sales (K Units), 2016-2021
Table 22. By Application - United States Scaffold-free Cell Culture Product Sales (K Units), 2022-2027
Table 23. Thermo Fisher (US) Corporation Information
Table 24. Thermo Fisher (US) Description and Major Businesses
Table 25. Thermo Fisher (US) Scaffold-free Cell Culture Product Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 26. Thermo Fisher (US) Scaffold-free Cell Culture Product Product
Table 27. Thermo Fisher (US) Recent Developments
Table 28. Corning (US) Corporation Information
Table 29. Corning (US) Description and Major Businesses
Table 30. Corning (US) Scaffold-free Cell Culture Product Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 31. Corning (US) Scaffold-free Cell Culture Product Product
Table 32. Corning (US) Recent Developments
Table 33. Lonza (Switzerland) Corporation Information
Table 34. Lonza (Switzerland) Description and Major Businesses
Table 35. Lonza (Switzerland) Scaffold-free Cell Culture Product Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 36. Lonza (Switzerland) Scaffold-free Cell Culture Product Product
Table 37. Lonza (Switzerland) Recent Developments
Table 38. Merck (Germany) Corporation Information
Table 39. Merck (Germany) Description and Major Businesses
Table 40. Merck (Germany) Scaffold-free Cell Culture Product Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 41. Merck (Germany) Scaffold-free Cell Culture Product Product
Table 42. Merck (Germany) Recent Developments
Table 43. ReproCELL (Japan) Corporation Information
Table 44. ReproCELL (Japan) Description and Major Businesses
Table 45. ReproCELL (Japan) Scaffold-free Cell Culture Product Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 46. ReproCELL (Japan) Scaffold-free Cell Culture Product Product
Table 47. ReproCELL (Japan) Recent Developments
Table 48. InSphero (Switzerland) Corporation Information
Table 49. InSphero (Switzerland) Description and Major Businesses
Table 50. InSphero (Switzerland) Scaffold-free Cell Culture Product Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 51. InSphero (Switzerland) Scaffold-free Cell Culture Product Product
Table 52. InSphero (Switzerland) Recent Developments
Table 53. Global Cell Solutions (US) Corporation Information
Table 54. Global Cell Solutions (US) Description and Major Businesses
Table 55. Global Cell Solutions (US) Scaffold-free Cell Culture Product Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 56. Global Cell Solutions (US) Scaffold-free Cell Culture Product Product
Table 57. Global Cell Solutions (US) Recent Developments
Table 58. Synthecon (US) Corporation Information
Table 59. Synthecon (US) Description and Major Businesses
Table 60. Synthecon (US) Scaffold-free Cell Culture Product Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 61. Synthecon (US) Scaffold-free Cell Culture Product Product
Table 62. Synthecon (US) Recent Developments
Table 63. 3D Biotek (US) Corporation Information
Table 64. 3D Biotek (US) Description and Major Businesses
Table 65. 3D Biotek (US) Scaffold-free Cell Culture Product Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 66. 3D Biotek (US) Scaffold-free Cell Culture Product Product
Table 67. 3D Biotek (US) Recent Developments
Table 68. Kuraray (Japan) Corporation Information
Table 69. Kuraray (Japan) Description and Major Businesses
Table 70. Kuraray (Japan) Scaffold-free Cell Culture Product Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 71. Kuraray (Japan) Scaffold-free Cell Culture Product Product
Table 72. Kuraray (Japan) Recent Developments
Table 73. Hamilton Company (US) Corporation Information
Table 74. Hamilton Company (US) Description and Major Businesses
Table 75. Hamilton Company (US) Scaffold-free Cell Culture Product Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 76. Hamilton Company (US) Scaffold-free Cell Culture Product Product
Table 77. Hamilton Company (US) Recent Developments
Table 78. Mimetas (Netherlands) Corporation Information
Table 79. Mimetas (Netherlands) Description and Major Businesses
Table 80. Mimetas (Netherlands) Scaffold-free Cell Culture Product Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 81. Mimetas (Netherlands) Scaffold-free Cell Culture Product Product
Table 82. Mimetas (Netherlands) Recent Developments
Table 83. Emulate (US) Corporation Information
Table 84. Emulate (US) Description and Major Businesses
Table 85. Emulate (US) Scaffold-free Cell Culture Product Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 86. Emulate (US) Scaffold-free Cell Culture Product Product
Table 87. Emulate (US) Recent Developments
Table 88. Nano3D Biosciences (US) Corporation Information
Table 89. Nano3D Biosciences (US) Description and Major Businesses
Table 90. Nano3D Biosciences (US) Scaffold-free Cell Culture Product Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 91. Nano3D Biosciences (US) Scaffold-free Cell Culture Product Product
Table 92. Nano3D Biosciences (US) Recent Developments
Table 93. QGel (Switzerland) Corporation Information
Table 94. QGel (Switzerland) Description and Major Businesses
Table 95. QGel (Switzerland) Scaffold-free Cell Culture Product Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 96. QGel (Switzerland) Scaffold-free Cell Culture Product Product
Table 97. QGel (Switzerland) Recent Developments
Table 98. Scaffold-free Cell Culture Product Production Capacity (K Units) of Key Manufacturers in United States Market, 2019-2021 (K Units)
Table 99. United States Scaffold-free Cell Culture Product Capacity Market Share of Key Manufacturers, 2019-2021
Table 100. Scaffold-free Cell Culture Product Market Opportunities & Trends in United States Market
Table 101. Scaffold-free Cell Culture Product Market Drivers in United States Market
Table 102. Scaffold-free Cell Culture Product Market Restraints in United States Market
Table 103. Scaffold-free Cell Culture Product Raw Materials
Table 104. Scaffold-free Cell Culture Product Raw Materials Suppliers in United States Market
Table 105. Typical Scaffold-free Cell Culture Product Downstream
Table 106. Scaffold-free Cell Culture Product Downstream Clients in United States Market
Table 107. Scaffold-free Cell Culture Product Distributors and Sales Agents in United States Market
List of FiguresFigure 1. Scaffold-free Cell Culture Product Product Picture
Figure 2. Scaffold-free Cell Culture Product Segment by Type
Figure 3. Scaffold-free Cell Culture Product Segment by Application
Figure 4. United States Scaffold-free Cell Culture Product Market Overview: 2020
Figure 5. United States Scaffold-free Cell Culture Product Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Scaffold-free Cell Culture Product Revenue, 2016-2027 (US$, Mn)
Figure 7. Scaffold-free Cell Culture Product Sales in United States Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Scaffold-free Cell Culture Product Revenue in 2020
Figure 9. Low-adhesion Microplates Product Picture
Figure 10. Hanging Drop Plates Product Picture
Figure 11. 3D Bioreactors Product Picture
Figure 12. 3D Petri Dishes Product Picture
Figure 13. By Type - United States Scaffold-free Cell Culture Product Sales Market Share, 2016-2027
Figure 14. By Type - United States Scaffold-free Cell Culture Product Revenue Market Share, 2016-2027
Figure 15. By Type - United States Scaffold-free Cell Culture Product Price (USD/Unit), 2016-2027
Figure 16. Cancer and Stem Cell Research
Figure 17. Drug Discovery and Toxicology
Figure 18. Tissue Engineering & Regenerative Medicine
Figure 19. By Application - United States Scaffold-free Cell Culture Product Sales Market Share, 2016-2027
Figure 20. By Application - United States Scaffold-free Cell Culture Product Revenue Market Share, 2016-2027
Figure 21. By Application - United States Scaffold-free Cell Culture Product Price (USD/Unit), 2016-2027
Figure 22. Thermo Fisher (US) Scaffold-free Cell Culture Product Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Corning (US) Scaffold-free Cell Culture Product Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Lonza (Switzerland) Scaffold-free Cell Culture Product Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Merck (Germany) Scaffold-free Cell Culture Product Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. ReproCELL (Japan) Scaffold-free Cell Culture Product Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. InSphero (Switzerland) Scaffold-free Cell Culture Product Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Global Cell Solutions (US) Scaffold-free Cell Culture Product Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Synthecon (US) Scaffold-free Cell Culture Product Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. 3D Biotek (US) Scaffold-free Cell Culture Product Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. Kuraray (Japan) Scaffold-free Cell Culture Product Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. Hamilton Company (US) Scaffold-free Cell Culture Product Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 33. Mimetas (Netherlands) Scaffold-free Cell Culture Product Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 34. Emulate (US) Scaffold-free Cell Culture Product Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 35. Nano3D Biosciences (US) Scaffold-free Cell Culture Product Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 36. QGel (Switzerland) Scaffold-free Cell Culture Product Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 37. United States Scaffold-free Cell Culture Product Production Capacity (K Units), 2016-2027
Figure 38. Scaffold-free Cell Culture Product Industry Value Chain
Figure 39. Marketing Channels